Targeted therapy for metastatic renal cell carcinoma

BACKGROUND: Several comparative randomised controlled trials (RCTs) have been performed including combinations of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors since the publication of a Cochrane Review on targeted therapy for metastatic renal cell carcinoma (mRCC) in 2008. This...

Full description

Saved in:
Bibliographic Details
Published in:Cochrane Database Syst Rev
Main Authors: Hofmann, Fabian, Hwang, Eu Chang, Lam, Thomas BL, Bex, Axel, Yuan, Yuhong, Marconi, Lorenzo SO, Ljungberg, Börje
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Ltd 2020
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8094280/
https://ncbi.nlm.nih.gov/pubmed/33058158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012796.pub2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items